Results from a preliminary study indicate that among patients with relapsing-remitting multiple sclerosis , treatment with nonmyeloablative hematopoietic stem cell transplantation was associated with improvement in measures of disability and quality of life, according to a study. Results from a preliminary study indicate that among patients with relapsing-remitting multiple sclerosis , treatment with nonmyeloablative hematopoietic stem cell transplantation was associated with improvement in measures of disability and quality of life, according to a study in the January 20 issue of JAMA .
http://ift.tt/154fGbP
http://ift.tt/154fGbP
No comments:
Post a Comment